Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · IEX Real-Time Price · USD
30.22
-0.73 (-2.36%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $1.85 billion as of July 2, 2024. Its market cap has increased by 45.96% in one year.
Market Cap
1.85B
Enterprise Value
1.41B
1-Year Change
45.96%
Ranking
Category
Stock Price
$30.22
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $1.85B, an increase of 122.20%. That is a compound annual growth rate of 22.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.90B | 34.42% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -58.03% |
| Dec 31, 2021 | 3.26B | 18.36% |
| Dec 31, 2020 | 2.76B | 230.32% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Warby Parker | 1.91B |
| BrightSpring Health Services | 1.90B |
| AMN Healthcare Services | 1.89B |
| Catalyst Pharmaceuticals | 1.87B |
| Beam Therapeutics | 1.86B |
| Amphastar Pharmaceuticals | 1.84B |
| NewAmsterdam Pharma Company | 1.83B |
| LeMaitre Vascular | 1.82B |